These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15742112)

  • 61. Higher sedentary energy expenditure in patients with Huntington's disease.
    Pratley RE; Salbe AD; Ravussin E; Caviness JN
    Ann Neurol; 2000 Jan; 47(1):64-70. PubMed ID: 10632102
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Unified Huntington's disease rating scale: a follow up.
    Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
    Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 64. GEORGE®: A Pilot Study of a Smartphone Application for Huntington's Disease.
    Waddell EM; Dinesh K; Spear KL; Elson MJ; Wagner E; Curtis MJ; Mitten DJ; Tarolli CG; Sharma G; Dorsey ER; Adams JL
    J Huntingtons Dis; 2021; 10(2):293-301. PubMed ID: 33814455
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Day and night shift schedules are associated with lower sleep quality in Evening-types.
    Martin JS; Laberge L; Sasseville A; Bérubé M; Alain S; Houle J; Hébert M
    Chronobiol Int; 2015 Jun; 32(5):627-36. PubMed ID: 26035480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.
    Aziz NA; Pijl H; Frölich M; van der Graaf AW; Roelfsema F; Roos RA
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1223-8. PubMed ID: 19174491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Time course of neurobehavioral alertness during extended wakefulness in morning- and evening-type healthy sleepers.
    Taillard J; Philip P; Claustrat B; Capelli A; Coste O; Chaumet G; Sagaspe P
    Chronobiol Int; 2011 Jul; 28(6):520-7. PubMed ID: 21797780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Actimeter-derived sleep and wake data and nocturnal ambulatory blood pressure estimation in subjects with stroke and transient ischaemic attack.
    Bhuachalla BN; Walsh S; Harbison J
    Int J Stroke; 2011 Oct; 6(5):388-91. PubMed ID: 21609418
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease.
    Corey-Bloom J; Gluhm S; Herndon A; Haque AS; Park S; Gilbert PE
    J Huntingtons Dis; 2016; 5(1):91-6. PubMed ID: 27003664
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Saccadic impairments in Huntington's disease.
    Peltsch A; Hoffman A; Armstrong I; Pari G; Munoz DP
    Exp Brain Res; 2008 Apr; 186(3):457-69. PubMed ID: 18185924
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantification of Daily-Living Gait Quantity and Quality Using a Wrist-Worn Accelerometer in Huntington's Disease.
    Keren K; Busse M; Fritz NE; Muratori LM; Gazit E; Hillel I; Scheinowitz M; Gurevich T; Inbar N; Omer N; Hausdorff JM; Quinn L
    Front Neurol; 2021; 12():719442. PubMed ID: 34777196
    [No Abstract]   [Full Text] [Related]  

  • 72. Predictors of neuropathological severity in 100 patients with Huntington's disease.
    Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
    Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Saccades in presymptomatic and early stages of Huntington disease.
    Blekher T; Johnson SA; Marshall J; White K; Hui S; Weaver M; Gray J; Yee R; Stout JC; Beristain X; Wojcieszek J; Foroud T
    Neurology; 2006 Aug; 67(3):394-9. PubMed ID: 16855205
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical correlates of mitochondrial function in Huntington's disease muscle.
    Turner C; Cooper JM; Schapira AH
    Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring.
    Kotschet K; Osborn S; Horne M
    Clin Park Relat Disord; 2023; 8():100179. PubMed ID: 36590454
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Objective assessment of progression in Huntington's disease: a 3-year follow-up study.
    Reilmann R; Kirsten F; Quinn L; Henningsen H; Marder K; Gordon AM
    Neurology; 2001 Sep; 57(5):920-4. PubMed ID: 11552034
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progression of symptoms in the early and middle stages of Huntington disease.
    Kirkwood SC; Su JL; Conneally P; Foroud T
    Arch Neurol; 2001 Feb; 58(2):273-8. PubMed ID: 11176966
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Automated Assessment of Movement Impairment in Huntington's Disease.
    Bennasar M; Hicks YA; Clinch SP; Jones P; Holt C; Rosser A; Busse M
    IEEE Trans Neural Syst Rehabil Eng; 2018 Oct; 26(10):2062-2069. PubMed ID: 30334742
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of Sleep Disruption and Sleep Quality in Naval Special Warfare Operators.
    Harris E; Taylor MK; Drummond SP; Larson GE; Potterat EG
    Mil Med; 2015 Jul; 180(7):803-8. PubMed ID: 26126252
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sleep and Circadian Rhythm Dysfunction in Animal Models of Huntington's Disease.
    Morton AJ
    J Huntingtons Dis; 2023; 12(2):133-148. PubMed ID: 37334613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.